Plus Therapeutics reported $138.68M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Baxter International USD 516.45M 2.17M Mar/2026
Dr.Reddys Laboratories INR 832.52M 144K Sep/2025
Haemonetics USD 46.83M 82K Dec/2025
Infinity Pharmaceuticals USD 90K 1000 Jun/2023
Northwest Biotherapeutics USD 1.52B 1.52B Sep/2025
Plus Therapeutics USD 138.68M 7.07M Dec/2025
Sanofi EUR 1.21B 8.25M Mar/2026
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
Teva Pharmaceutical Industries USD 1.16B 16.72M Mar/2026